aTYR PHARMA INC
ATYR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001339970
No open-market purchases or sales by aTYR PHARMA INC insiders were filed in the last 90 days; 89 institutions reported holding it in 13F filings for Q2 2026, worth $23.2M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding aTYR PHARMA INC changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 41 | 41 | 0 |
| Shares | 35.7M | 36.7M | +1.04M (+2.9%) |
| Value | $77.0M | $58.7M | −$18.4M (−23.8%) |
New holders (7)
Institutions that held aTYR PHARMA INC at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pale Fire Capital SE | 55,857 | $88.3K | 0.01% |
| Gsa Capital Partners LLP | 27,559 | $44.0K | 0.00% |
| Virtu Financial LLC | 13,662 | $22.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 11,961 | $18.9K | 0.00% |
| Simplex Trading, LLC | 9,032 | $14.0K | 0.00% |
| UBS Group AG | 4,399 | $6.95K | 0.00% |
| Qube Research & Technologies Ltd | 188 | $297 | 0.00% |
Sold out (7)
Institutions that held aTYR PHARMA INC at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Occudo Quantitative Strategies LP | 54,892 | $118.6K |
| Susquehanna International Group, LLP | 46,634 | $100.7K |
| Vontobel Holding Ltd. | 30,000 | $64.8K |
| Two Sigma Securities, LLC | 12,001 | $25.9K |
| Schonfeld Strategic Advisors LLC | 11,100 | $24.0K |
| Clearview Wealth Advisors LLC | 500 | $1.08K |
| ICA Group Wealth Management, LLC | 75 | $162 |